Cargando…
An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
Background: Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver c...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827060/ https://www.ncbi.nlm.nih.gov/pubmed/31546614 http://dx.doi.org/10.3390/cancers11101410 |
_version_ | 1783465238730899456 |
---|---|
author | Svinarenko, Michael Katz, Sarah-Fee Tharehalli, Umesh Mulaw, Medhanie A. Maier, Harald J. Sunami, Yoshiaki Fischer, Sarah K. Chen, Yuexin Heurich, Sabine Erkert, Lena Tannapfel, Andrea Wirth, Thomas Schirmbeck, Reinhold Seufferlein, Thomas Lechel, André |
author_facet | Svinarenko, Michael Katz, Sarah-Fee Tharehalli, Umesh Mulaw, Medhanie A. Maier, Harald J. Sunami, Yoshiaki Fischer, Sarah K. Chen, Yuexin Heurich, Sabine Erkert, Lena Tannapfel, Andrea Wirth, Thomas Schirmbeck, Reinhold Seufferlein, Thomas Lechel, André |
author_sort | Svinarenko, Michael |
collection | PubMed |
description | Background: Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver carcinogenesis. Methods: We used inducible liver-specific transgenic mouse strains to analyze the consequences of NF-κB/p65 activation mimicking chronic inflammation and subsequent p53 loss. Results: Ikk2(ca) driven NF-κB/p65 activation in mice results in liver fibrosis, the formation of ectopic lymphoid structures and carcinogenesis independent of p53 expression. Subsequent deletion of Trp53 led to an increased tumor formation, metastasis and a shift in tumor differentiation towards intrahepatic cholangiocarcinoma. In addition, loss of Trp53 in an inflammatory liver resulted in elevated chromosomal instability and indicated a distinct aberration pattern. Conclusions: In conclusion, activation of NF-κB/p65 mimicking chronic inflammation provokes the formation of liver carcinoma. Collateral disruption of Trp53 supports tumor progression and influences tumor differentiation and heterogeneity. |
format | Online Article Text |
id | pubmed-6827060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68270602019-11-18 An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation Svinarenko, Michael Katz, Sarah-Fee Tharehalli, Umesh Mulaw, Medhanie A. Maier, Harald J. Sunami, Yoshiaki Fischer, Sarah K. Chen, Yuexin Heurich, Sabine Erkert, Lena Tannapfel, Andrea Wirth, Thomas Schirmbeck, Reinhold Seufferlein, Thomas Lechel, André Cancers (Basel) Article Background: Most liver tumors arise on the basis of chronic liver diseases that trigger inflammatory responses. Besides inflammation, subsequent defects in the p53-signaling pathway frequently occurs in liver cancer. In this study, we analyzed the consequences of inflammation and p53 loss in liver carcinogenesis. Methods: We used inducible liver-specific transgenic mouse strains to analyze the consequences of NF-κB/p65 activation mimicking chronic inflammation and subsequent p53 loss. Results: Ikk2(ca) driven NF-κB/p65 activation in mice results in liver fibrosis, the formation of ectopic lymphoid structures and carcinogenesis independent of p53 expression. Subsequent deletion of Trp53 led to an increased tumor formation, metastasis and a shift in tumor differentiation towards intrahepatic cholangiocarcinoma. In addition, loss of Trp53 in an inflammatory liver resulted in elevated chromosomal instability and indicated a distinct aberration pattern. Conclusions: In conclusion, activation of NF-κB/p65 mimicking chronic inflammation provokes the formation of liver carcinoma. Collateral disruption of Trp53 supports tumor progression and influences tumor differentiation and heterogeneity. MDPI 2019-09-21 /pmc/articles/PMC6827060/ /pubmed/31546614 http://dx.doi.org/10.3390/cancers11101410 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Svinarenko, Michael Katz, Sarah-Fee Tharehalli, Umesh Mulaw, Medhanie A. Maier, Harald J. Sunami, Yoshiaki Fischer, Sarah K. Chen, Yuexin Heurich, Sabine Erkert, Lena Tannapfel, Andrea Wirth, Thomas Schirmbeck, Reinhold Seufferlein, Thomas Lechel, André An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
title | An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
title_full | An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
title_fullStr | An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
title_full_unstemmed | An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
title_short | An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
title_sort | ikk/nf-κb activation/p53 deletion sequence drives liver carcinogenesis and tumor differentiation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827060/ https://www.ncbi.nlm.nih.gov/pubmed/31546614 http://dx.doi.org/10.3390/cancers11101410 |
work_keys_str_mv | AT svinarenkomichael anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT katzsarahfee anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT tharehalliumesh anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT mulawmedhaniea anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT maierharaldj anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT sunamiyoshiaki anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT fischersarahk anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT chenyuexin anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT heurichsabine anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT erkertlena anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT tannapfelandrea anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT wirththomas anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT schirmbeckreinhold anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT seufferleinthomas anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT lechelandre anikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT svinarenkomichael ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT katzsarahfee ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT tharehalliumesh ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT mulawmedhaniea ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT maierharaldj ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT sunamiyoshiaki ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT fischersarahk ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT chenyuexin ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT heurichsabine ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT erkertlena ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT tannapfelandrea ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT wirththomas ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT schirmbeckreinhold ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT seufferleinthomas ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation AT lechelandre ikknfkbactivationp53deletionsequencedriveslivercarcinogenesisandtumordifferentiation |